| CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises | |
| Tong, Bing; Wang, Mengzhao | |
| 2018 | |
| 卷号 | 14期号:21页码:2179-2188 |
| 关键词 | anti-CD47 monoclonal antibody bispecific antibody cancer CD47 CD47 blockade immune checkpoint inhibitor immunotherapy phagocytosis SIRP tumor-associated macrophage |
| ISSN号 | 1479-6694 |
| DOI | 10.2217/fon-2018-0035 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6360376 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Tong, Bing,Wang, Mengzhao. CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises[J],2018,14(21):2179-2188. |
| APA | Tong, Bing,&Wang, Mengzhao.(2018).CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises.,14(21),2179-2188. |
| MLA | Tong, Bing,et al."CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises".14.21(2018):2179-2188. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论